Barrett’s Study
Prospective, Randomized Trial Comparing the Safety and Effectiveness of the Interscope EndoRotor Mucosal Resection System with Continued Ablative Therapy in Subjects with Refractory Dysplastic Barrett’s Esophagus
Protocol # CLIN 0010
US FDA IDE # G170106
NCT 03364114
EndoRotor - Low Grade Squamous Cell Carcinoma (SCC)
EndoRotor is not yet approved for sale for primary resection of (Squamous Cell Carcinoma) SCC. Current clinical trials are enrolling refractory Barrett’s Esophagus patients.
CAUTION - Investigational device. Limited by Federal (or United States) law to investigational use.